Describe Naloxone in detail.
Definition & Use
Naloxone is a competitive opioid (μ-receptor) antagonist used to reverse the effects of opioids — principally life-threatening respiratory depression and sedation, in opioid overdose or excessive perioperative opioid effect. It is given intravenously (also IM/intranasal) and titrated in small doses to restore adequate breathing.
Key Points
Naloxone has a rapid onset but a short duration of action — often shorter than the opioid it is reversing — so re-sedation and respiratory depression can recur, requiring repeated doses or an infusion and continued monitoring. Reversing opioids also reverses analgesia (causing pain, hypertension, tachycardia) and can precipitate acute withdrawal in opioid-dependent patients, so it is titrated carefully.
CLINICAL PEARL
Give naloxone in small titrated doses to reverse respiratory depression while preserving some analgesia, and watch for re-narcotisation — naloxone is often shorter-acting than the opioid, so effects can return and repeat doses/an infusion may be needed.
Wider Uses & Cautions
Beyond the operating theatre, naloxone is a cornerstone of the emergency management of opioid overdose, where it is given by any available route to restore breathing, and take-home naloxone programmes have extended its use into the community. The same cautions apply everywhere: it is short-acting relative to many opioids, so the patient must be observed for the return of respiratory depression after the initial response; and in the opioid-dependent patient a large dose can precipitate a distressing acute withdrawal syndrome, so it is titrated to restore adequate ventilation rather than to fully reverse all opioid effect.
CLINICAL PEARL
The trap with naloxone is its short duration: it may wear off before the opioid it reversed, so the patient can become re-narcotised, and it is therefore titrated to restore breathing and the patient kept under observation, with repeat doses or an infusion ready.
Note
In opioid overdose naloxone can be given by almost any route to restore breathing, but the same short duration means the patient is never left unobserved after an apparent recovery.
Shorter acting than most opioids — observe or infuse.
KEY POINT
Key points TO remember
- Naloxone: competitive μ-opioid antagonist; reverses opioid respiratory depression/sedation.
- Titrate in small IV doses to restore breathing while preserving some analgesia.
- Short-acting — shorter than many opioids → re-sedation can recur (repeat doses/infusion, monitor).
- Reverses analgesia & can precipitate acute withdrawal in dependence.
EXAM TIP
Sources: Morgan & Mikhail’s Clinical Anesthesiology; Miller’s Anesthesia; Ajay Yadav’s Short Textbook of Anaesthesia.
All questions in Intravenous Anaesthetic Agents
- Q1Describe Intravenous Induction Agents — Overview in detail. ★
- Q2Describe Propofol in detail. ★
- Q3Describe Thiopentone in detail. ★
- Q4Describe Ketamine in detail. ★
- Q5Total Intravenous Anaesthesia ★
- SN1Write a short note on Etomidate. ★
- SN2Write a short note on Intra-arterial Injection of Thiopentone. ★
- SN3Describe Midazolam in detail.
- SN4Describe Propofol Infusion Syndrome in detail.
- SN5Describe Context-Sensitive Half-Time in detail.
- SN6Write a short note on Fentanyl. ★
- SN7Describe Naloxone in detail.